Endocrinology, Vol 121, 1424-1431, Copyright © 1987 by Endocrine Society

ARTICLES

Inhibitory effects of interleukin 1 on insulin secretion, insulin biosynthesis, and oxidative metabolism of isolated rat pancreatic islets

S Sandler, A Andersson and C Hellerstrom
Department of Medical Cell Biology, Uppsala University, Sweden.

Recent observations suggest a role for interleukin 1 (IL-1), a macrophage-derived cytokine, in the autoimmune B cell destruction, which is observed in type 1 diabetes. In the present study we have investigated the effects of IL-1 and two other cytokines, namely tumor necrosis factor (TNF) and interferon-gamma (IFN-gamma) on the pancreatic B cell paying particular attention to insulin production and glucose metabolism. Rat pancreatic islets were isolated and kept in tissue culture for 5 days. The islets were subsequently transferred to media containing medium RPMI 1640 plus 0.5% human serum with or without additions of human recombinant preparations of either IL-1 (25 U/ml), TNF (1000 U/ml), or IFN-gamma (500 U/ml), and cultured for another 48 h. After the culture period the islets were subjected to light microscope examination and different functional tests in short-term incubations in the absence of cytokines. IL-1 was found to reduce insulin release in culture and totally inhibit glucose-stimulated insulin release in short-term incubations. Islet (pro)insulin biosynthesis, glucose oxidation, and oxygen uptake at 16.7 mM glucose were partially inhibited by IL-1. The DNA content of islets cultured with IL-1 was decreased and may partly explain these latter findings. However, inhibition of glucose oxidation could not be seen in islets exposed to IL-1 in short-term experiments only. By light microscopy there were marked signs of degeneration in IL-1 treated islets. TNF and IFN-gamma were essentially without effect on islet morphology or function. The results of this study indicate that IL-1 may be cytotoxic to islet B cells. The primary toxic action of IL-1 seems to involve factors other than an impaired islet glucose metabolism.

This article has been cited by other articles:

				D. Mokhtari, J. W. Myers, and N. Welsh The MAPK Kinase Kinase-1 Is Essential for Stress-Induced Pancreatic Islet Cell Death Endocrinology, June 1, 2008; 149(6): 3046 - 3053. [Abstract] [Full Text] [PDF]

				T. Rydgren, O. Vaarala, and S. Sandler Simvastatin Protects against Multiple Low-Dose Streptozotocin-Induced Type 1 Diabetes in CD-1 Mice and Recurrence of Disease in Nonobese Diabetic Mice J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 180 - 185. [Abstract] [Full Text] [PDF]

				M. Koulmanda, E. Budo, S. Bonner-Weir, A. Qipo, P. Putheti, N. Degauque, H. Shi, Z. Fan, J. S. Flier, H. Auchincloss Jr., et al. Modification of adverse inflammation is required to cure new-onset type 1 diabetic hosts PNAS, August 7, 2007; 104(32): 13074 - 13079. [Abstract] [Full Text] [PDF]

				H. Ghanaat-Pour, Z. Huang, M. Lehtihet, and A. Sjoholm Global expression profiling of glucose-regulated genes in pancreatic islets of spontaneously diabetic Goto-Kakizaki rats J. Mol. Endocrinol., August 1, 2007; 39(2): 135 - 150. [Abstract] [Full Text] [PDF]

				A. Borjesson and C. Carlsson Altered proinsulin conversion in rat pancreatic islets exposed long-term to various glucose concentrations or interleukin-1{beta} J. Endocrinol., February 1, 2007; 192(2): 381 - 387. [Abstract] [Full Text] [PDF]

				M. Montolio, M. Biarnes, N. Tellez, J. Escoriza, J. Soler, and E. Montanya Interleukin-1{beta} and inducible form of nitric oxide synthase expression in early syngeneic islet transplantation J. Endocrinol., January 1, 2007; 192(1): 169 - 177. [Abstract] [Full Text] [PDF]

				T. Rydgren, D. Bengtsson, and S. Sandler Complete Protection Against Interleukin-1{beta}-Induced Functional Suppression and Cytokine-Mediated Cytotoxicity in Rat Pancreatic Islets In Vitro Using an Interleukin-1 Cytokine Trap. Diabetes, May 1, 2006; 55(5): 1407 - 1412. [Abstract] [Full Text] [PDF]

				M. Johansson, G. Mattsson, A. Andersson, L. Jansson, and P.-O. Carlsson Islet Endothelial Cells and Pancreatic {beta}-Cell Proliferation: Studies in Vitro and during Pregnancy in Adult Rats Endocrinology, May 1, 2006; 147(5): 2315 - 2324. [Abstract] [Full Text] [PDF]

				P.-O. Carlsson, F. Palm, A. Andersson, and P. Liss Markedly Decreased Oxygen Tension in Transplanted Rat Pancreatic Islets Irrespective of the Implantation Site Diabetes, March 1, 2001; 50(3): 489 - 495. [Abstract] [Full Text]

				R. D. Molano, T. Berney, H. Li, P. Cattan, A. Pileggi, C. Vizzardelli, N. S. Kenyon, C. Ricordi, L. C. Burkly, and L. Inverardi Prolonged Islet Graft Survival in NOD Mice by Blockade of the CD40-CD154 Pathway of T-Cell Costimulation Diabetes, February 1, 2001; 50(2): 270 - 276. [Abstract] [Full Text]

				W. Schepp, K. Dehne, H. Herrmuth, K. Pfeffer, and C. Prinz Identification and functional importance of IL-1 receptors on rat parietal cells Am J Physiol Gastrointest Liver Physiol, November 1, 1998; 275(5): G1094 - G1105. [Abstract] [Full Text] [PDF]

				Z. Ma, M. Landt, A. Bohrer, S. Ramanadham, D. M. Kipnis, and J. Turk Interleukin-1 Reduces the Glycolytic Utilization of Glucose by Pancreatic Islets and Reduces Glucokinase mRNA Content and Protein Synthesis by a Nitric Oxide-dependent Mechanism J. Biol. Chem., July 11, 1997; 272(28): 17827 - 17835. [Abstract] [Full Text] [PDF]

				N. Welsh and N. Welsh Interleukin-1beta-induced Ceramide and Diacylglycerol Generation May Lead to Activation of the c-Jun NH(2)-terminal Kinase and the Transcription Factor ATF2 in the Insulin-producing Cell Line RINm5F J. Biol. Chem., April 5, 1996; 271(14): 8307 - 8312. [Abstract] [Full Text] [PDF]